AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1134
-0.0273 (-19.40%)
At close: Nov 17, 2026, 4:00 PM EST
0.1180
+0.0046 (4.06%)
Pre-market: Nov 18, 2026, 6:27 AM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $5.66 million as of November 17, 2026. It is the 44,159th most valuable company in the world and the 5,821st biggest in the United States. Its market cap has decreased by 47.18% in one year.
Market Cap
5.66M
Enterprise Value
-2.97M
1-Year Change
-47.18%
Global Rank
Country Rank
#5,821 United States
Category
ChartMarket Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $5.66M, a decrease of -91.11%. That is a compound annual growth rate of -35.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 5.66M | -56.56% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 8.26M |
| Ensysce Biosciences | 8.14M |
| Immuron | 8.13M |
| Vistagen Therapeutics | 8.01M |
| Longeveron | 7.94M |
| Kiora Pharmaceuticals | 7.83M |
| Moleculin Biotech | 7.66M |
| Soligenix | 7.50M |